Transactions, M&A, Finance Raise
Mid-size pharma CDMO company
- Acquisition of a drug product manufacturing business for generic APIs in the Netherlands
Swiss Startup in cell line development
- Strategy development, business plan and investor presentation,
approach of financial investors
Multinational biopharmaceutical company
- Acquisition of a US manufacturing site
US mid-size pharma company in cardiovascular drug development
- Business model, investor presentation, approach of outside US licensing partners
Multinational pharma company
- Divestment of three manufacturing sites in drug product and drug substance
Multinational pharma company
- Divestment of a non-business in performance materials
Multinational pharma company
- Strategic licensing collaboration combined with equity investment between a multinational pharmaceutical company and a biotech start-up
Listed German biotech company
- Joint venture between a biotech start-up and mid-size pharmaceutical company in biomolecule purification
Shenzen listed fine chemical company
- Acquisition of a UK based fine chemical business
Multinational material supplier
- Divestment of 70% joint venture equity share to a local supplier in China
Strategy, Business Development
European mid-market Life Science investor
- Market mapping and identification of potential acquisition opportunities in new markets such as Cell and Gene Therapy
Multinational CDMO company
- Indentification of business potential and value creation opportunities in highly active pharmaceutical ingredients "hAPIs"
Multinational mid-size fine chemical company
- Development and implementation of strategic planning process
Multinational pharma company
- Market mapping and identification of potential acquisition opportunities in immunotherapy and monoclonal antibodies
Multinational material supplier
- Identification of value creation opportunities in new markets, technologies and business models